Advanced medical imaging and analysis enters FDA guidance, accelerates preclinical trials

The data driving R&D and commercialization decisions in medtech innovation, like histology, can be underpowered and don’t expound the entire product efficacy story. The processing of those images and the associated analysis can be painfully slow and in many cases subject to detrimental observer-based bias and variability – a simple issue of the human eye…

Q: Can advanced medical imaging like microCT accelerate preclinical trials? A: Yes.

Preclinical testing and training industry leader T3 Labs and imaging and image analysis experts ImageIQ use advanced quantitative imaging to accelerate preclinical research for medical device and pharmaceutical innovators, bring welcome evolution to regulatory processes and data quality. The challenge – speeding up the medtech development cycle Medical device and biologic innovators, especially in the…